All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their cases have been ignored.
Tag: Food and Drug Administration
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.
Lead-Tainted Applesauce Highlights Failings in Food Safety System
Hundreds of American children were poisoned last year. Records show how, time and again, the contamination went unnoticed.
What to Know About Lead Poisoning in Children
Hundreds of children sickened from high levels of lead in applesauce pouches last year put a spotlight on lapses in the food-safety system.
Lead Levels in Children’s Applesauce May Be Traced to Cinnamon Additive
The F.D.A. is investigating the sources of cinnamon and other ingredients produced outside the U.S. as the possible cause of lead poisoning in dozens of children. Advocates are urging mandatory testing of lead in food.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.